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Abstract The Rhodobacter capsulatus genes encoding the 
NUOE and NUOF subunits, equivalent to the 24 kDa and 51 
kDa subunits of the mammalian mitochondrial complex I, have 
been sequenced. According to the nucleotide sequence, the 
NUOE subunit is 389 amino acids long and has a molecular 
mass of 41.3 kDa. In comparison to the mitochondrial equivalent 
subunit, NUOE is extended at the C terminus by more than 150 
amino acids. The NUOF subunit is 431 amino acids long and has 
a molecular mass of 47.1 kDa. A subcomplex containing both the 
NUOE and NUOF subunits was extracted by detergent 
treatment of R. capsulatus membranes and immuno-purified. 
This subcomplex is homologous to the mitochondrial FP 
fragment. Mass spectrometry after trypsin treatment of the 
NUOE subunit validates the atypical primary structure deduced 
from the sequence of the gene. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
NADH-CoQ reductase (or complex I) is the first compo-
nent of the bacterial or mitochondrial respiratory chains. This 
enzyme catalyzes the oxidation of NADH and the reduction 
of ubiquinone with the concomitant ejection of 4 protons out-
side the bacterial cell or mitochondria [1,2]. In bovine mito-
chondria, structural analysis has revealed this complex to be 
composed of 43 different subunits. A number of cofactors 
(one FMN and 4-6 iron-sulfur clusters) are key components 
in the redox process. The precise assignment of these bound 
cofactors to the different subunits is still a matter of debate. 
Years ago, the subfractionation of the mitochondrial complex 
I led to the identification of three different subcomplexes 
called HP, IP and FP with the following features [3,4]. The 
HP subcomplex (hydrophobic proteins) is a non-soluble mul-
timeric aggregate of hydrophobic subunits. It is partly built up 
of the 7 subunits encoded by the mitochondrial episome (also 
called ND subunits: ND1 through ND6 and ND4L). This 
hydrophobic fraction plays an important role in the anchoring 
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PNE, synthetic peptide corresponding to the NUOE subunit N-
terminus 
of complex I to the internal mitochondrial membrane and also 
in the proton channeling through the membrane. The second 
subcomplex, called IP fragment (iron-sulfur proteins), is a 
soluble domain made up of numerous subunits and contains 
some of the iron-sulfur clusters of complex I. The third sub-
complex has been called FP fragment (flavoprotein) as it was 
proved to contain the FMN molecule and iron-sulfur clusters 
[5,6]. This soluble domain, when purified from bovine com-
plex I, is composed of three subunits with molecular masses of 
51, 24 and 9 kDa and displays NADH-ferricyanate oxidore-
ductase activity. The 51 kDa subunit is believed to be the 
catalytic subunit since it binds NADH [7,8]. One 4Fe-4S clus-
ter and one FMN are probably liganded to this subunit. The 
second iron-sulfur cluster borne by the FP fragment is a 2Fe-
2S cluster and is localized to the 24 kDa subunit. Complex I 
from bacteria, a more simple model of complex I, is being 
studied in different laboratories. In Escherichia coli and Para-
coccus denitrificans, complex I is believed to be an assembly of 
at least 14 different subunits [9,10]. The genes encoding these 
subunits are clustered in one operon (so-called nuo for 
NAHD-ubiquinone oxidoreductase in E. coli and nqo for 
NADH-quinone oxidoreductase in P. denitrificans). Primary 
structure analysis has indicated that the 14 bacterial subunits 
are homologous to 14 subunits which are part of the bovine 
mitochondrial complex I. Seven bacterial subunits are equiv-
alent to the mitochondrial ND subunits and seven others are 
the counterparts of the 75 kDa, 51 kDa, 49 kDa, 30 kDa, 24 
kDa, 23 kDa and 20 kDa subunits. Hence, two of the bacte-
rial subunits are highly similar to the two main subunits which 
compose the mitochondrial FP fragment (51 kDa and 24 kDa 
subunits). The third subunit of the mitochondrial FP fragment 
called 9 kDa has no counterpart amongst the subunits en-
coded by the bacterial operons. The present report shows 
that an FP-like subcomplex made up of two subunits homol-
ogous to the mitochondrial 51 kDa and 24 kDa subunits can 
be immuno-purified from the R. capsulatus membranes. Strik-
ingly enough, the R. capsulatus NUOE subunit has a very 
long C terminus extension which is not found in the equiva-
lent subunits of the different bacterial and mitochondrial com-
plexes I. 
2. Materials and methods 
An R. capsulatus B10 genomic DNA library constructed in lambda 
was screened with a bovine cDNA fragment coding for the 51 kDa 
subunit. Inserts from the positive clones were subcloned in plasmids 
and sequenced as described previously [11]. A 12 amino acid peptide 
called peptide PNE corresponding to the N terminus of the NUOE 
subunit was synthesized on an Applied Biosystems 432A peptide syn-
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thesizer (the PNE sequence was MLRRLHATQPDSC, in which the C 
terminus cysteine was an additional residue added for cross-linking to 
BSA). The HPLC purified peptide was cross-linked to maleimide-ac-
tivated BSA and the final conjugate was used to raise antibodies in 
rabbits. Cytoplasmic membranes from aerobically grown wild type R. 
capsulatus BIO strain were prepared as follows. Cells were grown in 
the dark in RCV medium [12] containing 30 mM lactate as a carbon 
source and harvested by centrifugation. They were resuspended in one 
tenth the initial volume in buffer A (50 mM HEPES, pH 7.5, 1 mM 
EDTA, 1 mM fi-mercaptoethanol, 2 lig/ml aprotinin, 1 (Xg/ml anti-
pain, 1 |ig/ml leupeptin, 1 (J.g/ml chymostatin, 0.5 u.g/ml pepstatin) and 
disrupted by passing through a cell disrupter (Constant Cell, War-
wick, UK) at a pressure of 1 kbar. Subcomplex extraction was per-
formed by treatment of the membranes with a stripping solution 
composed of 50 mM HEPES pH 7.5, 20 mM NaCl, 1 mM EDTA 
and 2% Glucopon (Glucopon 215 CS UP is a proprietary detergent 
from Henkel, France). After centrifugation (15 min, 90000 rpm, 4°C) 
the supernatant was diluted five-fold in phosphate saline buffer and 
loaded onto a 1 ml immunoaffinity column of immobilized anti-PNE 
antibodies. The immunoaffinity column was generated essentially as 
described by Haines et al. [13]. Very briefly, the anti-PNE antibodies 
were immobilized on a protein A crosslinked Sepharose CL6B (Phar-
macia) then chemically crosslinked with dimethylpimelimidate. The 
Glucopon solubilized R. capsulatus membrane extract was loaded 
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atcgatgccgtcgccaagggacaccaaccggcggatgtgtccgccatcatcggcacgatggatgtcgtgttcggggagattgaccgctg ATG CTG 
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CGC CGC TTG CAC GCC ACC CAA CCC GAC AGC TTC GCC TTT ACC CCC GCC AAC CGC GCC TGG GCG GAA GCG CAG ATC 
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ACC AAA TAC CCC GAG GGC CGT CAG GCC TCG GCG GTG ATC CCG CTC TTG TTC CGC GCG CAG GAA CAG GAA GGC TGG 
T K Y P E G R Q A S A V I P L L F R A Q E Q E G W 
CTG ACG AAG CCC GCG ATC GAA TAC GTG GCC GAC CTG CTC GAC ATG CCC TAT ATC CGC GTG CTC GAA GTG GCG 
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TTC TAC TTC ATG TTC CAG CTG CAG CCC ACG GGC TCG GTC GCG CAT ATT CAG GTC TGC GGC ACC ACC AGC TGC 
F Y F M F Q L Q P T G S V A H I Q V C G T T S C M 
ATC ATG GGC TCG GAA AAC CTG ATC GAG GTC TGC AAG CGC AAG ATC TCG CAT CAT CCG CAT GCG CTT TCC GCC GAT 
I M G S E N L I E V C K R K I S H H P H A L S A D 
GGC AAG TTC AGC TGG GAA GAG GTC GAA TGT CTG GGC GCC TGT GCC AAT GCG CCG ATG GCC CAG ATC GGC AAG GAT 
G K F S W E E V E C L G A C A N A P M A Q I G K D 
TAC TTC GAA GAC CTG ACC GAG GCG GGG CTG GAG CGG CTG ATC GAC GAT CTG GCG GCG GGC AAG GCG CCG GTG CCG 
Y F E D L T E A G L E R L I D D L A A G K A P V P 
GGG TCG GAA ATC GGG CGC TTC GGG GCG GAA CCG GCC ACC GGC CTG ACC AGC TGC ACG ACG ACC TCC GGC GCG CGC 
G S E I G R F G A E P A T G L T S C T T T S G A R 
GAG GCG CAG AAC GGC TCG GTC GCG CGG GCG GTT GCG GTG GGC GAT GGC ACG CGC CGG ATC GAC GGG ACC GAG GTG 
E A Q N G S V A R A V A V G D G T R R I D G T E V 
CTT TCC GCC CCA TGG CAG GTC TCG GGG CAG ATG GGC GCG ATC GGT CTG ATG ACG GCG CGG CCG CGC TCG GCG 
L S A P W Q V S G Q M G A I G L M T A R P R S A 
CAG CAG CAG GCG GCG GCC GAG GCG GCG AAA GCG GCG GCG GCG GCA GAG TCG GCC GGG GGG ACG TCA ACC CCG 
V Q Q Q A A A E A A K A A A A A E S A G G T S T P 
GCT GCA CCG GTG GCC GGG GCG GCG GGG AAA GCC GCA CAA ACG GCT GAA ACC GCT GCG CAG AAA CCG CTT GCG CTG 
A A P V A G A A G K A A Q T A E T A A Q K P L A L 
GTT GCA CCC CGC GAC GGC AAG GCC GAT GAG CTG CAG AAG ATC GAG AGC ATC GGA CCG GCG CTC GAG GCG CTT CTG 
V A P R D G K A D E L Q K I E S I G P A L E A L L 
CAC GAT CTG GGC ATC TTC CAT TTC GAC CAG ATC GCC GCC TGG GGC GCG GGC GAA ATT GCC TGG ATG GAC GGC 
H D L G I F H F D Q I A A W G A G E I A W M D G 
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CAT ACG CTG ATC GAA GGC GCG CTG ATC GCC GGT TTC GCC ATG 
H T L I E G A L I A G F A M 
GGC GCG CGG GCG GCC TAT ATC TAT ATT CGC GGC GAA TAT GTC CGC GAA AAG GAG GCC CTG CAG GCC GCC ATC GAC 
G A R A A Y I Y I R G E Y V R E K E A L Q A A I D 
GAA TGC TAC GAG GCC GGG CTG ATC GGC AAG AAC GCC TGC CGC TCG GAC TAT GAT TTC GAC GTC TAT CTG CAC CAC 
E C Y E A G L I G K N A C R S D Y D F D V Y L H H 
GGT GCG GGC GCC TAT ATC TGC GGC GAG GAA ACC GCG CTT CTG GAA AGC CTT GAG GGC AAG AAG GGG ATG CCG CGG 
G A G A Y I C G E E T A L L E S L E G K K G M P R 
ATG AAA CCG CCG TTC CCG GCG GGC TCG GGG CTT TAT GGC TGC CCG ACG ACG GTG AAC AAC GTC GAA TCC ATC GCC 
M K P P F P A G S G L Y G C P T T V N N V E S I A 
GTC GTG CCG ACG ATC CTG CGC CGT GGT GGT GCC TGG TTC GCG GGC ATC GGG CGG CCG AAC AAC ACC GGC GTC AAG 
V V P T I L R R G G A W F A G I G R P N H T G V K 
CTG TTC GCG ATG TCG GGG CAC GTC AAC ACC CCC TGC GTC GTC GAA GAA GCC ATG TCG ATC AGC ATG AAG GAG CTG 
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Fig. 1. Sequence of the Clal-Mscl restriction fragment of lambda clones, selected from an R. capsulatus genomic library by screening with a 
cDNA coding for the bovine 51 kDa subunit as a probe. The derived amino acid sequences of the three open reading frames nuoE, orfA and 
nuoF are indicated below the DNA sequence. Termination codons are marked by an asterisk. The nucleotide sequence data reported in this fig-
ure will appear in the EMBL, GenBank and DDBJ Nucleotide Sequence Databases under accession number Y10142. 
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onto the column and allowed to recirculate through the column over-
night at 4°C. The column was then washed extensively in buffer A. 
Finally, the immuno-adsorbed components were released by an acidic 
washing step with a solution composed of 100 mM HCl-glycine pH 
2.8, 0.4% Glucopon. Collected fractions were immediately neutralized 
and analyzed on SDS-PAGE. Proteins were sequenced after electro-
phoretic transfer onto PVDF membranes as described [14]. 
The identification of the peptides generated by tryptic cleavage of 
NUOE was performed by mass spectrometry as follows. The silver 
stained NUOE spot was excised from the polyacrylamide gel and in-
gel digested with trypsin after iodoacetamide derivatization according 
to published procedures [15]. The resultant pep tide mixture was em-
bedded into a matrix of a-cyano-4-hydroxy-ftvms-cinnamic acid and 
analyzed by MALDI mass spectrometry. The mass spectra were ob-
tained on a Bruker BIFLEX mass spectrometer. For spectrum cali-
bration, trypsin autolytic fragments were taken as standards. 
3. Results and discussion 
Lambda clones, containing a DNA fragment encompassing 
the R. capsulatus gene coding for the 51 kDa catalytic subunit 
of the respiratory complex I, were recovered by screening and 
R. capsulatus DNA genomic library using a cDNA clone cod-
ing for the bovine mitochondrial 51 kDa subunit as a probe. 
Restriction digest fragments of the positive clones were cloned 
and sequenced. A Clal-Mscl fragment 3.3 kb long (Fig. 1) 
was proved to contain 3 putative open reading frames. The 
first open reading frame from base 90 to base 1259 encodes a 
41 kDa protein which is related to the bovine 24 kDa subunit 
(Fig. 2). As a consequence this gene was called nuoE following 
the nomenclature of the E. coli nuo genes [10]. The second 
open reading frame from base 1359 to 1802 was called orfA 
and encodes a potential polypeptide with a molecular mass of 
14.8 kDa. This putatively expressed polypeptide has no equiv-
alent with either of the known subunits of the mitochondrial 
or bacterial complexes I. The last open reading frame from 
base 1995 to base 3290 encodes a 47 kDa protein which is 
equivalent to the bovine 51 kDa subunit. This gene was called 
nuoF. The overall organization of this R. capsulatus DNA 
fragment with the nuoE gene located upstream of the nuoF 
gene is similar to what is found in the E. coli nuo operon, 
except that in R. capsulatus a supernumerary open reading 
frame (orfA) is located between nuoE and nuoF. In the P. 
denitrificans operon, Yagi's group has discovered two open 
reading frames called urfl and urf2 located between the 
nqo2 and nqol genes (nqo2 and nqol genes are the equivalents 
of the R. capsulatus nuoE and nuoF genes respectively) [9]. 
Neither of these two urfi, looks similar to the R capsulatus 
orfA. Analysis of our lambda clones showed that in R. cap-
sulatus the nuoE and nuoF genes are located in the close vi-
cinity and upstream of the nuoH-nuoN gene cluster previously 
sequenced (not shown) [11,16]. 
A closer look at the primary structures of the NUOE and 
NUOF proteins has given additional information. The R. 
capsulatus NUOF protein is 38.5% identical to the E. coli 
NUOF subunit, about 67% identical to the bovine 51 kDa 
subunit and up to 85% identical to the P. denitrificans 
NQOl subunit. Four cysteine residues which are believed to 
be involved in the binding of a 4Fe-4S cluster (C346, C349, 
C352 and C392, R. capsulatus numbering) are strictly con-
served in all the subunits. Four cysteine residues are also in-
variant in the NUOE equivalent subunits (Fig. 2). All the 
NUOE equivalent subunits are highly similar except for their 
C terminal parts which are heterogeneous in size (Fig. 2). The 
E. coli NUOE subunit is the shortest one with 166 amino 
acids and a molecular mass of about 19 kDa. The human 
and bovine subunits, as mitochondrially imported and proc-
essed forms, are 217 amino acids and close to 24 kDa, and the 
P. denitrificans with 239 amino acids is 26 kDa [9,10,17]. Ac-
cording to the DNA sequence, the R. capsulatus NUOE sub-
unit would have 389 amino acids and a molecular mass of 
41 264 Da. This subunit looks very atypical and is nearly twice 
as big as the corresponding mammalian mitochondrial sub-
unit. In comparison to the P. denitrificans subunit, the R. cap-
sulatus NUOE subunit appeared to be extended at the C 
terminus by 150 amino acids. This predicted extension is ala-
nine rich, without specific motifs, and contains only one addi-
tional cysteine residue. It is not highly hydrophobic and is not 
predicted to form a transmembranous helix. To rule out the 
possibility of any DNA sequencing artifact, we paid careful 
attention to accurate sequencing of various subcloned frag-
ments of the nuoE gene as well as a number of PCR fragments 
MHENQQPQTEAFELSAAERSAVEHEMHKY3DPRAAS- -IEALKIVOKQRCWVPDGAIHAIADVLCiPASDVEGVATFYSOiEKGPVGRHV- 1RYCDSVVG 
GAGGALFVKRDTPENNPETPFDFTPENYKRIEAIVKKYPEGHKAAAVLPVLDLAQRQNGWLPISAMNKVAEILQVPPMRVYEVATFYTMYNRKPVGKY-HIQVCTTTPC 
GAGGALFVKRDTPENNPDTPFDFTPENYKRIEAIVKKYPEGHKAAAVLPVLDljAQRQNGWijPISAMNKVAP^Vr.QVPPMRVYFVATFYTMYNRKPVGKY-HIQVCTTTPC 
MLRRLSPIQPDS-FEF7PANLSWARAQMTKYPEGRQQSAIIPVLWRAQEQr,GWLSRPAIEYCADLLGHPYlRALfc:VATFYFMFQL0PVGSVAPII0ICGTTTC 
MLRRLHATQPDS-FAFTPANRAWAEAQITKYPEGRQASAVIPLLFRAQEQEGWLTKPAIEYVAm.UDMPYiRVLEVASFYFMFQLQPTGSVAHIQVGGTTSG 
i ' . COli NUOE 
b o v i Tie 24 kDa 
human 2 4 kDa 
P. denitrificans NQ02 
R. capsulatus NUOE 
98 HINGYQGIQAALEKKLNIKPGQTTFDGRFTLLPTCCLGNCDKGPNMMIDEDTHAHLTPEAIPELLERYK 166 E. coli NUOS 
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109 M L R N S D S I L E A I Q K K L G I K V G E T T P D K L F T L I E V E G L G A C V N A P M V Q I N D N Y Y E D L T A K D I E E I I D E L K A G K I P K P G P R S G R F S C E P A G G L T S L T E P P K G P G F G V Q A G L 217 human 24 kDa 
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102 MIMGSENLIEVGKRKISHHPHALSADGKFSWEEVECLGACANAPMAQIGKDYFEDLTEAGLERLIDDLAAGKAPVPGSEIGRFGAEPATGLTSCTTTSGAREAQNGSVA R. capsulatus NUOE 
210 
211 
RALRLGDS IKRTDGTEVPTTTPWT.ATQNGV 2 3 9 
RAVAVGDGTRRIDGTEVRLSAPWQVSGQMGAIGLMTARPRSAVQQQAAAEAAKAAAAAESAGGTSTPAAPVAGAAGKAAQTAETAAQKPLALVAPRDGKADELQKIESI 
denitrificans NQ02 
capsulatus XUOE 
320 GPALEALLHDLGIFHFDQIAAWGAGEIAWMDGNLKGFPGRASGDRWWQAKTIVEEGLDRFLERAKTNNY 3 8 9 P.. capsulatus NUOE 
Fig. 2. Comparison of the polypeptide sequences of the R. capsulatus NUOE subunit, the E. coli NUOE subunit, the bovine and human 24 
kDa subunits (as processed mitochondrially imported subunits) and the P. denitrificans NQ02 subunit. Identical residues between the R. capsu-
latus NUOE and the human 24 kDa subunits are marked by dots, invariant cysteine residues are indicated by open circles. The tryptic peptides 
of the R. capsulatus NUOE subunit identified by MALDI mass spectrometry (see Fig. 4) are underlined and labelled A to I and A' to C . 
Alignment was computerized using the Clustal method with the PAM 250 weight table. 
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66 kDa — 
46 kDa — 
30 kDa — 
21.4 kDa — 
Fig. 3. SDS polyacrylamide gel and Western blot analysis of the 
fractions eluted from the anti-PNE affinity column. Proteins recov-
ered from the affinity column by acidic elution were precipitated 
overnight with 5 volumes of ethanol at —20°C (lanes 1, 2, 3 and 5). 
Membrane lysates collected in the flow through of the column dur-
ing sample loading were also run as controls after being ethanol 
precipitated (lanes 4 and 6). Samples were run through a 12% poly-
acrylamide gel then stained with Coomassie (lane 1) or silver (lane 
2). After electrophoretic transfer to PVDF membranes, proteins 
were identified using an anti-NUOF antibody (lanes 3 and 4) or an 
anti-PNE antibody (lanes 5 and 6). 
overlapping this gene. No error was found in our consensus 
sequence. Accordingly, we set up immunoaffinity experiments 
to check the size of the expressed subunit in the R. capsulatus 
membranes so as to definitively ascertain the existence of an 
elongated C terminus in the R. capsulatus NUOE subunit. 
Antibodies were raised against a synthetic peptide (called 
PNE) corresponding to the deduced N terminus sequence of 
the NUOE subunit. Membrane samples from the R. capsula-
tus BIO strain were analyzed by 2D electrophoresis in poly-
acrylamide gel. The anti-PNE antibodies specifically revealed 
one polypeptide with an apparent molecular mass of 42 kDa 
and a pi value close to 5.5 (not shown). These features are 
very close to the theoretical values of 41 264 Da and pi 5.42 
deduced from the sequence of the gene. The selectivity of our 
antibody allowed us to set up experiments with the aim to 
immuno-purify the whole complex I or some fraction of it 
from R. capsulatus membrane fractions. Membranes were di-
luted in a 2% Glucopon solution (see Section 2) and soluble 
material was recovered after centrifugation. This soluble frac-
tion was loaded onto a column of anti-PNE antibodies im-
mobilized on a protein A-crosslinked Sepharose. After wash-
ing, the eluted fractions (see Section 2) were analyzed on SDS-
PAGE. These fractions contained 2 major proteins in a 
grossly stoichiometric amount as revealed by Coomassie 
blue staining (Fig. 3, lane 1). This subcomplex fraction ap-
peared at least 95% pure as shown by Coomassie and intense 
silver staining (Fig. 3, lanes 1 and 2). Apparent molecular 
masses of 49 and 43 kDa were estimated for these two pro-
teins. The two proteins were specifically detected by an anti-
NUOF subunit antibody or by the anti-PNE antibody respec-
tively (Fig. 3). The identity of these two proteins was further 
confirmed by sequencing of their N termini. The N terminus 
of the biggest subunit was shown to be MLNDHDRIFT and 
that of the smaller one MLRRLHATQP. These N termini 
perfectly matched those deduced from the sequenced genes 
coding for the NUOF and NUOE subunits respectively 
(Fig. 1). This confirmed that the two newly sequenced nuoE 
and nuoF genes are truly expressed in R. capsulatus and that 
the NUOE and NUOF subunits, purified as a soluble hetero-
dimer after detergent extraction of the membranes, are in 
close contact in complex I. We also checked on an aliquot 
of the particulate material from the column if the NUOE-
NUOF subcomplex might have some catalytic activity. In-
deed, some deamino-NADH dependent nitroblue tetrazolium 
reductase activity was present in the immobilized protein frac-
tion on the column after the extensive washes. 
To ascertain that the mass of the NUOE subunit was re-
lated to a C terminus extension in comparison to other species 
NUOE subunits, we analyzed by MALDI mass spectrometry 
the peptide mixture obtained after tryptic digestion of the 
NUOE spot in the polyacrylamide gel. Eleven different pep-
tides generated by trypsin cleavage of the NUOE subunit were 
unambiguously identified (Fig. 4). Among these peptides, two 
(peptide H from amino acid 288 to 306 and peptide I from 
amino acid 371 to 379) are part of the C terminus extension 
which has no counterpart in the equivalent bacterial or mito-
chondrial subunits (Figs. 2 and 4). This analysis ascertains 
that the amino acid sequence deduced from the DNA se-
quence of the nuoE gene is accurate and that the R. capsulatus 
NUOE subunit is significantly bigger than the other equiva-
lent subunits known so far. 
In chloroplasts, three subunits of the NADH dehydrogen-
ase domain of complex I (75 kDa, 51 kDa and 24 kDa) are 
apparently missing. This observation was taken by Friedrich 
et al. as an indication that in chloroplasts 'complex I' may 
work in a different way to the mitochondrial complex I [18]. 
Chloroplast complex I was hypothesized by these authors to 
be a NADPH or a ferredoxin:plastoquinone oxidoreductase. 
The discovery that in R. capsulatus NUOE and NUOF, which 
are the equivalents of the 24 kDa and 51 kDa subunits, are 
expressed is a clear indication that the R. capsulatus complex I 
is more of the mitochondrial type than of the chloroplast type. 
Friedrich et al. have shown that stripping the E. coli cyto-
plasmic membranes under acidic conditions with a buffer con-
taining the technical alkylglucoside APG 225 (a Glucopon 
equivalent manufactured by Henkel, Diisseldorf, Germany) 
led to the isolation of a whole active complex I [19]. Unlike 
this work, many different attempts at solubilizing the whole R. 
capsulatus complex I in our laboratory or others [20] have 
thus far proved unsuccessful probably because of the great 
instability of this complex I. The experiments we report here 
clearly show that in the case of R. capsulatus, Glucopon treat-
ment of the membranes led to the isolation of a subcomplex 
composed of the NUOE and NUOF subunits only. This sub-
complex was stripped from the membrane whatever the pH of 
the stripping solution in the range of 6-8. Indeed, our purifi-
cation protocol yielded a subcomplex of complex I very sim-
ilar to the mitochondrial FP fragment. The mitochondrial FP 
fragment is composed of 3 different subunits, 51 kDa, 24 kDa 
and 9 kDa. An equivalent of the 9 kDa subunit, the role of 
which is unclear in the mitochondrial complex I, is absent in 
our preparation. None of the genes or other ORFs of the 
bacterial NADH-ubiquinone oxidoreductase operons ana-
lyzed so far encode a protein similar to the mammalian 
9 kDa ([9,10] and unpublished data for R. capsulatus). Fur-
thermore, no significant homology was observed between the 
C terminal extension of R. capsulatus NUOE subunit and the 
bovine 9 kDa. Consequently, the possibility for the R. capsu-
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1619.82 
1772.87 
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Fig. 4. MALDI mass spectrum of a tryptic digest of the NUOE subunit. After in-gel tryptic digestion of the NUOE band, the eluted peptide 
mixture was analyzed as described in Section 2. The identified tryptic peptides are labelled A to I, and A' and C, their positions and sequences 
are given in the table. Peptides A', C and G correspond to partially digested peptides. The peptide at mlz 1045.60 is a trypsin autolytic frag-
ment which partially overlaps the signal of peptide I. These two peaks are clearly distinguishable when this doublet peak is magnified (not 
shown). The major peak of the spectrum was unidentified. The theoretical masses of the protonated peptides are given in the table. They corre-
spond to the monoisotopic masses for peptides G, E and I and to average masses for peptides A-D, C , F and H. Positions of the peptides A 
to I, A' and C are underlined in Fig. 2. (a) Mass of the Cys-195 carboxyamidomethylated peptide F. 
latus NUOE subunit to behave as a fusion protein that would 
be the equivalent of both the bovine 24 kDa and 9 kDa seems 
to be ruled out. In the case of P. denitrificans attempts to 
purify complex I after detergent treatment of the membranes 
have led to the partial purification of a heterodimer with 
NADH-ubiquinone oxidoreductase activity [21]. The two sub-
units had molecular masses of 48 and 25 kDa. An antibody 
raised against this heterodimer was proved to crossreact with 
the bovine 51 kDa subunit of the bovine mitochondrial com-
plex I suggesting that the two-subunit NADH-ubiquinone ox-
idoreductase component purified from the P. denitrificans 
membranes might also be an FP-like subcomplex I [22]. Fur-
thermore, it has been recently reported by Yagi's group that 
the P. denitrificans NQOl and NQ02 subunits tend to asso-
ciate in a dimeric aggregate when co-expressed in E. coli [23]. 
The above data as well as our immuno-purification of an FP-
like fragment from the R. capsulatus membrane are clear in-
dications that the NUOE and NUOF subunits interact closely 
and strongly in the bacterial complex I. 
The R capsulatus NUOE subunit has a very peculiar fea-
ture because of a very long C terminal alanine rich extension 
which is not found in the equivalent subunits from other 
species. Because this extension is predicted not to contain 
any hydrophobic helix it is probably not involved in the mem-
brane anchorage of complex I. At the present time, we do not 
know if this extended C terminus is related to a specific struc-
tural component in the R capsulatus complex I or whether it 
is associated with the fact that R capsulatus is a photosyn-
thetic bacterium. Mutagenesis studies are under way to check 
the role, if any, of this C terminal extension. 
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